Status:
COMPLETED
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this clinical research study is to learn if outpatients with bipolar mania who are partially nonresponsive to lithium or valproate monotherapy can achieve stable symptoms on a combinati...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men and women \> or = to 18 years of age meeting Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for bipolar I disorder, currently experiencing a manic or mixed episode with a history of one or more manic or mixed episodes or sufficient severity to require hospitalization and/or treatment with a mood stabilizer or antipsychotic.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1270 Patients enrolled
Trial Details
Trial ID
NCT00261443
Start Date
September 1 2005
End Date
October 1 2009
Last Update
April 18 2023
Active Locations (83)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuscaloosa Va Medical Center
Tuscaloosa, Alabama, United States, 35404
2
Pravin Kansagra, M.D.
Anaheim, California, United States, 92801
3
Psychopharmacology Research Network Of Torrance
Cerritos, California, United States, 90703
4
Atp Clinical Research, Inc.
Costa Mesa, California, United States, 92626